The MS-specific, differential antibody response to EBV antigens confirms an altered immunological response to EBV in MS patients.
Variant-adapted COVID-19 vaccines are recommended for patients with inflammatory bowel disease (IBD). However, many patients rely on pre-existing immunity by original vaccines or prior infections.
Discover our latest innovations and exciting insights - now on Bluesky. The NMI is now represented on the Bluesky platform. In our latest article, we share an exciting success story from our collabora
The congress theme “People first! - Individual, personal, professional” invites you to take part in exciting symposia and workshops that deal with topics such as person-centered care, pain in wound tr
Toxicological test methods generate raw data and provide instructions on how to use these to determine a final outcome such as a classification of test compounds as hits or non-hits.
Biocompatibility is a criterion for the approval of medical devices that come into direct or indirect contact with patients. For SMEs in particular, its verification is therefore as important as it is
BioCompFinder Dr. Fabian Körte Biofunctionalized Surfaces +49 7121 51530-845 E-Mail anzeigen There is a wide range of medical devices that have direct or indirect patient contact, and the differences
How can we as innBW make even better use of our synergies? Last Friday, representatives from several institutes met at the NMI to discuss the idea of a digital platform. How can we as innBW make even
Spin-offs & Start-ups The NMI relies on spin-offs as the royal road for technology transfer and promotes research-based start-up projects that involve complex and risky development work. The results o
Development of Microelectrode Arrays Dr. Peter D. Jones Group Leader Biomedical Micro and Nano Engineering +49 7121 51530-800 E-Mail anzeigen Microelectrode Arrays (MEAs) are instrumental in electroph
